Woo C. Shin
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer.
Journal: Oncotarget
Published: September 14, 2015
MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer.
Journal: Oncotarget
Published: October 01, 2014
MicroRNA-221 governs tumor suppressor HDAC6 to potentiate malignant progression of liver cancer.
Journal: Journal of hepatology
Published: August 08, 2014
HDAC6 sustains growth stimulation by prolonging the activation of EGF receptor through the inhibition of rabaptin-5-mediated early endosome fusion in gastric cancer.
Journal: Cancer letters
Published: May 07, 2014
Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model.
Journal: Journal of applied toxicology : JAT
Published: February 27, 2014
HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT.
Journal: Cancer research
Published: January 23, 2014
MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer.
Journal: Cancer letters
Published: September 05, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026